Ma J, Arnold H K, Lilly M B, Sears R C, Kraft A S
Hollings Cancer Center at the Medical University of South Carolina, Charleston, SC 29425, USA.
Oncogene. 2007 Aug 2;26(35):5145-53. doi: 10.1038/sj.onc.1210323. Epub 2007 Feb 12.
The Pim protein kinases are serine threonine protein kinases that regulate important cellular signaling pathway molecules, and enhance the ability of c-Myc to induce lymphomas. We demonstrate that a cascade of events controls the cellular levels of Pim. We find that overexpression of the protein phosphatase (PP) 2A catalytic subunit decreases the activity and protein levels of Pim-1. This effect is reversed by the application of okadaic acid, an inhibitor of PP2A, and is blocked by SV40 small T antigen that is known to disrupt B subunit binding to PP2A A and C subunits. Pim-1 can coimmunoprecipitate with the PP2A regulatory B subunit, B56beta, but not B56alpha, gamma, delta, epsilon or B55alpha. Using short hairpin RNA targeted at B56beta, we demonstrate that decreasing the level of B56beta increases the half-life of Pim-1 from 0.7 to 2.8 h, and decreases the ubiquitinylation level of Pim-1. We also find that Pin1, a prolyl-isomerase, is capable of binding Pim-1 and leads to a decrease in the protein level of Pim-1. On the basis of these observations, we hypothesize that phosphorylated Pim-1 binds Pin1 allowing the interaction of PP2A through B56beta. Dephosphorylation of Pim-1 then allows for ubiquitinylation and protein degradation of Pim-1.
Pim蛋白激酶是丝氨酸苏氨酸蛋白激酶,可调节重要的细胞信号通路分子,并增强c-Myc诱导淋巴瘤的能力。我们证明了一系列事件控制着Pim的细胞水平。我们发现蛋白磷酸酶(PP)2A催化亚基的过表达会降低Pim-1的活性和蛋白水平。这种作用可通过应用冈田酸(一种PP2A抑制剂)来逆转,并被已知会破坏B亚基与PP2A A和C亚基结合的SV40小T抗原所阻断。Pim-1可与PP2A调节性B亚基B56β共免疫沉淀,但不能与B56α、γ、δ、ε或B55α共免疫沉淀。使用靶向B56β的短发夹RNA,我们证明降低B56β的水平会使Pim-1的半衰期从0.7小时增加到2.8小时,并降低Pim-1的泛素化水平。我们还发现脯氨酰异构酶Pin1能够结合Pim-1并导致Pim-1的蛋白水平降低。基于这些观察结果,我们推测磷酸化的Pim-1结合Pin1,从而允许PP2A通过B56β相互作用。Pim-1的去磷酸化随后允许Pim-1的泛素化和蛋白降解。